Cargando…
Single application hybrid interstitial brachytherapy for cervical cancer: an institutional approach during the COVID-19 pandemic
PURPOSE: To ease anesthesia and inpatient strain during the COVID-19 pandemic, our institution’s policy for hybrid intracavitary-interstitial brachytherapy (IC/ISBT) for cervical cancer (CC) was modified from multiple applications (MA) treated over 2 separate weeks (7 Gy × 4) to a single-application...
Autores principales: | Damast, Shari, Tien, Christopher J., Young, Melissa, Altwerger, Gary, Ratner, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867238/ https://www.ncbi.nlm.nih.gov/pubmed/35233237 http://dx.doi.org/10.5114/jcb.2022.113058 |
Ejemplares similares
-
GSOR10 Presentation Time: 3:15 PM: Single Implant Hybrid Interstitial Brachytherapy for Cervical Cancer during the COVID-19 Pandemic: An Institutional Approach
por: Damast, Shari, et al.
Publicado: (2021) -
Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer
por: Qian, Jack M., et al.
Publicado: (2017) -
A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience
por: Murakami, Naoya, et al.
Publicado: (2019) -
High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma
por: Damast, Shari, et al.
Publicado: (2015) -
Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience
por: Ren, Xiaojun, et al.
Publicado: (2022)